Recombinant TechnologyExpression of single-chain Fv-Fc fusions in Pichia pastoris
Introduction
The modular nature of antibody molecules allows for an almost unlimited number of domain rearrangements and fusions. Antibody engineering allows the researcher to design and use a variety of binding domains, effector domains, as well as non-antibody fusion partners (Chamow and Ashkenazi, 1999, Hoogenboom, 1997). One of the most useful antibody fragments is the single-chain Fv (scFv) in which the isolated antibody VH and VL domains are joined by a short peptide linker (Bird et al., 1988, Huston et al., 1988). This monovalent, minimal binding fragment is favored for antibody phage display techniques and phage antibody library construction (Marks et al., 1991, McCafferty et al., 1990).
Once a scFv has been isolated from a phage display library, the binding domain can be characterized with respect to affinity, epitope, and biological activity, as well as subjected to further affinity maturation. The scFv can be used as is, or engineered into other formats (Fv, Fab, (Fab′)2, IgG, or fused to other proteins).
For some applications the scFv itself is the desired format. The small size of the scFv, its rapid clearance from the blood, and tumor penetration properties make it the format of choice for tumor targeting and radioimmunoimaging applications (Adams et al., 1995, Adams et al., 1998, Yokata et al., 1992). The single-chain nature of the scFv is also best-suited for intracellular immunization (intrabody) applications (Marasco, 1997). However for other uses, it would be desirable to transfer the antigen-binding properties of the scFv into a full length IgG, to take advantage of avidity effects, effector functions, and the prolonged serum half-life of an immunoglobulin. Increasing the serum half-life of scFv is particularly important for efficient in vivo antigen neutralization since the t1/2β of a typical scFv is only 3.5 h in mice (Huston et al., 1996).
One approach is to directly engineer a phage displayed scFv into a full length IgG and express it in mammalian cells (Persic et al., 1997). However this approach requires separate cloning steps for the VH and VL domains, and establishing a stable antibody secreting cell line can be time consuming. An alternate approach would be to engineer the scFv into a more ‘IgG-like’ structure that can be accomplished in a single cloning step, and that can be expressed at high levels in a eucaryotic microorganism such as yeast. We have constructed a vector to rapidly express an scFv-Fc fusion (wherein the scFv is fused to the hinge, CH2, and CH3 domains of human IgG1) in the methylotrophic yeast Pichia pastoris. The scFv-Fc fusion can easily be constructed in a single cloning step from a scFv and is secreted at high levels as a glycosylated dimer from Pichia cultures. The scFv-Fc fusion retains the affinity and specificity of the parent scFv, combined with the bivalency, prolonged serum half-life, and the Fc-mediated ADCC (antibody-dependent cellular cytotoxicity) of an IgG. These yeast-produced scFv-Fc fusions will be useful to rapidly characterize candidate scFv isolated from phage antibody libraries before converting to a full-length IgG, or as an alternative format in its own right.
Section snippets
Cells and media
Pichia pastoris strain GS115 was obtained from Invitrogen, San Diego, CA. SKBR-3 and SK-OV-3 cells were obtained from the ATCC (American Type Culture Collection, Rockville, MD). Media used: YPD, yeast extract peptone dextrose medium (1% yeast extract, 2% peptone, 2% dextrose); YPDS, YPD medium plus 1 M sorbitol; BMGY, buffered glycerol complex medium (1% yeast extract, 2% peptone, 100 mM phosphate buffer pH 6.0, 1.34% YNB, 4×10−5% biotin, 1% glycerol); BMMY, buffered methanol complex medium (1%
Plasmid constructions
We have constructed a plasmid for the expression of single-chain antibody Fv domains (scFv) fused to the human IgG1 Fc domain to make a bivalent, ∼106,000 molecular weight scFv-Fc fusion (Fig. 1). Plasmid pPIgG1 for the expression of the scFv-Fc fusions (comprising the scFv followed by the hinge, CH2 and CH3 domains of human IgG1) is based on the Pichia pastoris expression plasmid pPICZαA (Invitrogen). This plasmid uses the alcohol oxidase (AOX1) promoter for high level expression of
Discussion
The single-polypeptide, minimally sized scFv antibody fragment is useful for the design and construction of phage display antibody libraries, as fusion proteins, and as intrabodies; in addition the small size is best suited to tumor targeting due to superior tissue penetration (Yokata et al., 1992). However useful, the scFv format suffers from a number of key limitations. The lack of avidity due to monovalent binding can limit the effectiveness and/or sensitivity of scFv fragments in many
Acknowledgements
We would like to thank Mr. Tom Purcell of Invitrogen Co. for helpful discussions, Mr. Steve Chen for technical assistance, and Dr. Chris Turk of UCSF for N-terminal sequence analysis. This work was partially funded by DAMD17-94-C-4034, DAMD17-94-J-4433, and NIH CA65559.
References (35)
- et al.
A TNF receptor antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono- and bivalent scFv derivative in insect cells
Immunotechnology
(1997) - et al.
Calculation of protein extinction coefficients from amino acid sequence data
Anal. Biochem.
(1989) - et al.
Immunoreactivity of allergen (Bet v 1) conjugated to crystalline bacterial cell surface layers (S-layers)
Immunotechnology
(1996) - et al.
NCOMP, a Windows-based computer program for noncompartmental analysis of pharmacokinetic data
J. Pharm. Sci.
(1996) - et al.
Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor
Mol. Immunol.
(1985) - et al.
By-passing immunization: human antibodies from V-gene libraries displayed on phage
J. Mol. Biol.
(1991) - et al.
Conjunction of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions
Anal. Biochem.
(1984) - et al.
An integrated vector system for the eukaryotic expression of antibodies and their fragments after selection from phage display libraries
Gene
(1997) - et al.
Design of cassette baculovirus vectors for the production of therapeutic antibodies in insect cells
Immunotechnology
(1995) - et al.
In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library
Immunotechnology
(1995)
Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site
J. Mol. Biol.
Effect of glycosylation on antibody function: implications for genetic engineering
Trends Biotechnol.
Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single chain Fv
Cancer Res.
Enhanced tumor specificity with stably iodinated 741F8-2 (sFv′)2, an anti-c-erbB-2 single chain Fv dimer
J. Nucl. Med.
Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies
Cancer Res.
Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries
Infect. Immun.
Single-chain antigen-binding proteins
Science
Cited by (111)
Recombinant monoclonal antibody production in yeasts: Challenges and considerations
2024, International Journal of Biological MacromoleculesProprotein convertase subtilisin/kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation
2016, Journal of Biological ChemistryCitation Excerpt :The three other sdAbs also predominantly recognize ΔM2 (data not shown). Chimeric sdAbs were then fused to a mouse IgG2a Fc domain, known to increase the half-life of sdAbs in plasma (38), followed by a C-terminal V5 tag (Fig. 1F). Each chimeric protein was produced in HEK293 cells and purified from 600 ml of spent media.
Fusion of hIgG1-Fc to <sup>111</sup>In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake
2015, Nuclear Medicine and BiologyCitation Excerpt :The Fc-fusion approach has been performed earlier with single chain antibody fragments (scFv) [12,13], which are also recombinant antibody fragments. These scFv-Fc fusion proteins have been produced and applied both in vitro and in vivo[18–20], and studies indeed show increased blood residential times of the constructs [21]. VHH-Fc fusion constructs have been developed and produced in plant cells [22–24] as well as in cultured murine [2] and human cell lines [5,25].
Improved production of two expansin-like proteins in Pichia pastoris and investigation of their functional properties
2014, Biochemical Engineering JournalFunctional expression of an scFv on bacterial magnetic particles by in vitro docking
2014, Biochemical and Biophysical Research CommunicationsSpecific binder for Lightning-Link® biotinylated proteins from an antibody phage library
2013, Journal of Immunological Methods